Skip to main content
. 2017 Jan 30;7:40516. doi: 10.1038/srep40516

Table 2. Characteristics of Placebo- and Antibiotic-Treated Cirrhotic and Control Rats.

Indexes Cirrhotic Rats
Control Rats
Placebo (n = 10) Antibiotics (n = 10) Placebo (n = 8) Antibiotics (n = 8)
Total protein (g/dL) 4.2 ± 0.8 5.0 ± 0.8 5.0 ± 0.4 5.2 ± 0.2
Albumin (g/dL) 1.9 ± 1.0 3.0 ± 0.3# 3.3 ± 0.2* 3.4 ± 0.2
Globulin (g/dL) 2.6 ± 0.6 2.4 ± 0.3 1.8 ± 0.1* 1.8 ± 0.2**
Albumin/Globulin 0.7 ± 0.3 1.3 ± 0.3# 1.9 ± 0.1* 1.9 ± 0.2**
ALT (U/L) 204.5 ± 94.8 112.2 ± 24.6# 44.0 ± 14.9* 56.4 ± 10.2**
AST (U/L) 546.3 ± 364.5 265.7 ± 56.9# 70.7 ± 9.7* 83.6 ± 9.0**
ALP (U/L) 221.1 ± 132.3 109.5 ± 53.8 28.3 ± 36.8* 30.0 ± 31.1**
GGT (U/L) 24.2 ± 13.4 16.2 ± 8.6 −2.7 + 1.6* −3.2 + 1.1**
TBIL (μmol/L) 39.3 ± 16.4 20.8 ± 10.7# 2.0 ± 0.0* 1.6 ± 0.9**
DBIL (μmol/L) 33.7 ± 13.9 16.5 ± 7.1# 2.0 ± 1.3* 2.4 ± 0.9**
IBIL (μmol/L) 5.2 ± 3.0 2.0 ± 2.6 −0.3 + 1.5* −0.8 + 1.1
Initial body weight (g) 217.2 ± 4.4 213.8 ± 7.3 214.2 ± 8.6 210.8 ± 8.0
Final body weight (g) 377.7 ± 48.5 390.0 ± 16.8 469.8 ± 10.2* 469.2 ± 13.3**
Body weight increase (g) 160.5 ± 45.7 176.2 ± 15.0 255.7 ± 11.4* 258.3 ± 9.4**
Spleen weight (g) 1.6 ± 0.3 1.3 ± 0.3# 0.9 ± 0.1* 0.9 ± 0.0**
Spleen weight/Final body weight (%) 4.4 ± 1.0 3.2 ± 0.6# 1.8 ± 0.1* 1.9 ± 0.1**
Ascites amount (mL) 24.3 ± 3.4 8.5 ± 2.3# / /
Ascites/Final body weight (mL/kg) 64.6 ± 7.2 23.4 ± 6.0# / /

Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; ALP, alkaline phosphatase; GGT, gamma-glutamyl transpeptidase; TBIL, total bilirubin; DBIL, direct bilirubin; IBIL, indirect bilirubin. The data are presented as the means ± standard deviation. *P < 0.05, placebo-treated normal rats versus placebo-treated cirrhotic rats; **P < 0.05, antibiotics-treated normal rats versus antibiotics-treated cirrhotic rats; #P < 0.05, antibiotics- versus placebo-treated cirrhotic rats. The unpaired Student’s t test with Bonferroni’s correction was used.